Literature DB >> 186541

Clinical trials of immunization with the Towne 125 strain of human cytomegalovirus.

S A Plotkin, J Farquhar, E Horberger.   

Abstract

The Towne 125 strain of human cytomegalovirus (CMV), adapted to growth in human diploid cell strain WI-38 and propagated in this cell line for 129 consecutive passages, was administered to male volunteers with or without preexisting antibodies to CMV. Infection was not achieved by intranasal administration. In contrast, subcutaneous inoculation of virus induced seroconversion in all seronegative volunteers and a booster antibody response in some previously seropositive individuals. Transient local reactions occured at the site of inoculation of the virus, but systemic symptoms and signs of disease were notably absent.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 186541     DOI: 10.1093/infdis/134.5.470

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  34 in total

1.  A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation.

Authors:  A Skaletskaya; L M Bartle; T Chittenden; A L McCormick; E S Mocarski; V S Goldmacher
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-26       Impact factor: 11.205

Review 2.  Herpesviruses.

Authors:  M C Timbury; E Edmond
Journal:  J Clin Pathol       Date:  1979-09       Impact factor: 3.411

3.  Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: induction of interferon-responsive RNAs.

Authors:  H Zhu; J P Cong; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

4.  Evaluation of Abbott CMV-M enzyme immunoassay for detection of cytomegalovirus immunoglobulin M antibody.

Authors:  L Schaefer; A Cesario; G Demmler; S Plotkin; S Stagno; C Elrod; J Ringler; N Tustin
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

5.  Molecular cloning and analysis of three cDNA clones homologous to human cytomegalovirus RNAs present during late infection.

Authors:  J Martinez; S C St Jeor
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

6.  Immunoglobulin G to virus-specific early antigens in congenital, primary, and reactivated human cytomegalovirus infections.

Authors:  G Gerna; P M Cereda; E Cattaneo; G Achilli; M G Revello
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

7.  Production of Cytomegalovirus Dense Bodies by Scalable Bioprocess Methods Maintains Immunogenicity and Improves Neutralizing Antibody Titers.

Authors:  Kirsten Schneider-Ohrum; Corinne Cayatte; Yi Liu; Zhaoti Wang; Alivelu Irrinki; Floro Cataniag; Nga Nguyen; Stacie Lambert; Hui Liu; Shahin Aslam; Greg Duke; Michael P McCarthy; Louise McCormick
Journal:  J Virol       Date:  2016-10-28       Impact factor: 5.103

8.  Congenital cytomegalovirus infection: a dilemma.

Authors:  M C Timbury
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-22

9.  Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains.

Authors:  T A Cha; E Tom; G W Kemble; G M Duke; E S Mocarski; R R Spaete
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

10.  Spontaneous activation of latent cytomegalovirus from murine spleen explants. Role of lymphocytes and macrophages in release and replication of virus.

Authors:  M C Jordan; V L Mar
Journal:  J Clin Invest       Date:  1982-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.